Applications and Limitations of Radiomics

Overview

Journal Phys Med Biol

Publisher IOP Publishing

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2016 Jun 9

PMID 27269645

Citations 521

Authors

Stephen S F Yip

Hugo J W L Aerts

Affiliations

Soon will be listed here.

Abstract

Radiomics is an emerging field in quantitative imaging that uses advanced imaging features to objectively and quantitatively describe tumour phenotypes. Radiomic features have recently drawn considerable interest due to its potential predictive power for treatment outcomes and cancer genetics, which may have important applications in personalized medicine. In this technical review, we describe applications and challenges of the radiomic field. We will review radiomic application areas and technical issues, as well as proper practices for the designs of radiomic studies.

Citing Articles

Radiomics in Dermatological Optical Coherence Tomography (OCT): Feature Repeatability, Reproducibility, and Integration into Diagnostic Models in a Prospective Study.

Widaatalla Y, Wolswijk T, Khan M, Halilaj I, Mosterd K, Woodruff H Cancers (Basel). 2025; 17(5).

PMID: 40075619 PMC: 11899706. DOI: 10.3390/cancers17050768.

Potential of Radiomics, Dosiomics, and Dose Volume Histograms for Tumor Response Prediction in Hepatocellular Carcinoma following Y-SIRT.

Mansouri Z, Salimi Y, Hajianfar G, Knappe L, Wolf N, Xhepa G Mol Imaging Biol. 2025; .

PMID: 40064820 DOI: 10.1007/s11307-025-01992-8.

Development and validation of a robust MRI-based nomogram incorporating radiomics and deep features for preoperative glioma grading: a multi-center study.

Bijari S, Rezaeijo S, Sayfollahi S, Rahimnezhad A, Heydarheydari S Quant Imaging Med Surg. 2025; 15(2):1125-1138.

PMID: 39995745 PMC: 11847178. DOI: 10.21037/qims-24-1543.

Radiomic Fingerprinting of the Peritumoral Edema in Brain Tumors.

Azemi G, Ieva A Cancers (Basel). 2025; 17(3).

PMID: 39941846 PMC: 11815925. DOI: 10.3390/cancers17030478.

Modernizing Neuro-Oncology: The Impact of Imaging, Liquid Biopsies, and AI on Diagnosis and Treatment.

Rafanan J, Ghani N, Kazemeini S, Nadeem-Tariq A, Shih R, Vida T Int J Mol Sci. 2025; 26(3).

PMID: 39940686 PMC: 11817476. DOI: 10.3390/ijms26030917.

References

Mu W, Chen Z, Liang Y, Shen W, Yang F, Dai R . Staging of cervical cancer based on tumor heterogeneity characterized by texture features on (18)F-FDG PET images. Phys Med Biol. 2015; 60(13):5123-39. DOI: 10.1088/0031-9155/60/13/5123. View

McNitt-Gray M, Hart E, Wyckoff N, Sayre J, Goldin J, Aberle D . A pattern classification approach to characterizing solitary pulmonary nodules imaged on high resolution CT: preliminary results. Med Phys. 1999; 26(6):880-8. DOI: 10.1118/1.598603. View

Diehn M, Nardini C, Wang D, McGovern S, Jayaraman M, Liang Y . Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A. 2008; 105(13):5213-8. PMC: 2278224. DOI: 10.1073/pnas.0801279105. View

Marusyk A, Almendro V, Polyak K . Intra-tumour heterogeneity: a looking glass for cancer?. Nat Rev Cancer. 2012; 12(5):323-34. DOI: 10.1038/nrc3261. View

Hatt M, Majdoub M, Vallieres M, Tixier F, Rest C, Groheux D . 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med. 2014; 56(1):38-44. DOI: 10.2967/jnumed.114.144055. View

Leijenaar R, Nalbantov G, Carvalho S, van Elmpt W, Troost E, Boellaard R . The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis. Sci Rep. 2015; 5:11075. PMC: 4525145. DOI: 10.1038/srep11075. View

Nie K, Chen J, Yu H, Chu Y, Nalcioglu O, Su M . Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol. 2008; 15(12):1513-25. PMC: 2791407. DOI: 10.1016/j.acra.2008.06.005. View

Cheng N, Fang Y, Yen T . The promise and limits of PET texture analysis. Ann Nucl Med. 2013; 27(9):867-9. DOI: 10.1007/s12149-013-0759-8. View

Yan J, Chu-Shern J, Loi H, Khor L, Sinha A, Quek S . Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET. J Nucl Med. 2015; 56(11):1667-73. DOI: 10.2967/jnumed.115.156927. View

10.

Zhang H, Tan S, Chen W, Kligerman S, Kim G, DSouza W . Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics. Int J Radiat Oncol Biol Phys. 2013; 88(1):195-203. PMC: 3875172. DOI: 10.1016/j.ijrobp.2013.09.037. View

11.

Mussurakis S, Buckley D, Coady A, Turnbull L, Horsman A . Observer variability in the interpretation of contrast enhanced MRI of the breast. Br J Radiol. 1996; 69(827):1009-16. DOI: 10.1259/0007-1285-69-827-1009. View

12.

Haberkorn U, Ziegler S, Oberdorfer F, Trojan H, Haag D, Peschke P . FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol. 1994; 21(6):827-34. DOI: 10.1016/0969-8051(94)90162-7. View

13.

Tateishi U, Kusumoto M, Nishihara H, Nagashima K, Morikawa T, Moriyama N . Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer. 2002; 95(4):835-42. DOI: 10.1002/cncr.10730. View

14.

Cook G, Yip C, Siddique M, Goh V, Chicklore S, Roy A . Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?. J Nucl Med. 2012; 54(1):19-26. DOI: 10.2967/jnumed.112.107375. View

15.

Nair V, Gevaert O, Davidzon G, Napel S, Graves E, Hoang C . Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res. 2012; 72(15):3725-34. PMC: 3596510. DOI: 10.1158/0008-5472.CAN-11-3943. View

16.

de Jong J, van Diest P, Baak J . Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest. 1995; 73(6):922-6. View

17.

Ellingson B, Lai A, Harris R, Selfridge J, Yong W, Das K . Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol. 2012; 34(3):533-40. PMC: 7964888. DOI: 10.3174/ajnr.A3253. View

18.

Henriksson E, Kjellen E, Wahlberg P, Ohlsson T, Wennerberg J, Brun E . 2-Deoxy-2-[18F] fluoro-D-glucose uptake and correlation to intratumoral heterogeneity. Anticancer Res. 2007; 27(4B):2155-9. View

19.

Steyerberg E, Vickers A, Cook N, Gerds T, Gonen M, Obuchowski N . Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2009; 21(1):128-38. PMC: 3575184. DOI: 10.1097/EDE.0b013e3181c30fb2. View

20.

Altman D, Lausen B, Sauerbrei W, Schumacher M . Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994; 86(11):829-35. DOI: 10.1093/jnci/86.11.829. View